Alexion Pharmaceuticals, Inc.

Advisors Asset Management, Inc. ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

8/26/2026

Shares

7,361

Value ($000)

1,352

Weight

0.0%

2013 Q4 - 2021 Q2 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	8/26/2026	1,352	0.0%	7,361	6/30/2021
2021 Q1	8/26/2026	1,141	0.0%	7,465	3/31/2021
2020 Q4	8/26/2026	1,678	0.0%	10,738	12/31/2020
2020 Q3	8/26/2026	1,158	0.0%	10,119	9/30/2020
2020 Q2	8/27/2026	1,185	0.0%	10,557	6/30/2020
2020 Q1	8/21/2026	992	0.0%	11,050	3/31/2020
2019 Q4	8/25/2026	1,728	0.0%	15,976	12/31/2019
2019 Q3	8/18/2026	1,730	0.0%	17,666	9/30/2019
2019 Q2	8/18/2026	2,684	0.0%	20,492	6/30/2019
2019 Q1	8/18/2026	2,528	0.0%	18,702	3/31/2019
2018 Q4	8/13/2026	1,921	0.0%	19,729	12/31/2018
2018 Q3	8/13/2026	2,734	0.0%	19,670	9/30/2018
2018 Q2	8/13/2026	2,288	0.0%	18,428	6/30/2018
2018 Q1	8/13/2026	1,745	0.0%	14,856	3/31/2018
2014 Q1	5/15/2014	5,900	0.1%	38,781	3/31/2014
2013 Q4	2/3/2014	4,036	0.1%	30,331	12/31/2013